CLSD - Clearside Corp Trailing Twelve Months Revenue Growth

Graphic logo of Clearside Corp (CLSD)

The development of Clearside Biomedical (CLSD) depends on the pace of micro-injector licensing and patent protection. Year-over-year sales growth over the last 12 months allows for the filtering of speculative noise, while -56.30 represents the current level of this metric. Clearside Biomedical aims for leadership in targeted drug delivery to the retina, with its primary revenue based on the commercialization of XIPERE for the treatment of macular edema.

CLSD Clearside Biomedical Inc: Sales Growth YoY (Last Twelve Months) in the range 02/11/2024 - 12/13/2025

Clearside Biomedical Inc (CLSD) - metric breakdowns and financial figures

- stock price and consensus target price:
Price Chart Clearside|CLSD - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Clearside Biomedical, Inc.|CLSD - Enterprise Value
- book capitalization data:
Book Value per Share Clearside Biomedical|CLSD - Company Book Value|Market Value to Book Value clearsidebio.com|CLSD - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Capital Coefficient Clearside Biomedical|CLSD - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Clearside Biomedical, Inc.|CLSD - Company Aggregate Debts|Debt to Book Value Ratio Clearside Biomedical, Inc.|CLSD - Company Long-Term Debts|Short-Term Debt Clearside Biomedical|Intermediate Coverage Ratio clearsidebio.com
- business earnings and investment ratios data:
CLSD - Net Profit|Expected Profit Clearside Biomedical|CLSD - P/E Multiple|Market Cap to Projected Earnings clearsidebio.com|CLSD - Price/Earnings to Growth Ratio|Company Value to EBITDA Clearside Biomedical Inc|CLSD - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Clearside Biomedical|CLSD - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months clearsidebio.com|CLSD - Earnings growth in current year|Projected earnings per share growth rate for next year Clearside Biomedical
- sales and revenue data:
CLSD - Revenue and Sales Volume|Company Future Sales Clearside|CLSD - P/S Multiple|Forward Price-to-Revenue Multiple Clearside Biomedical, Inc.|CLSD - Sales Growth YoY (TTM)
Summary company analytics:Clearside - CLSD
Signature product of Clearside Biomedical, Inc.

Licensing microcatheters to Big Pharma creates a steady revenue stream dependent on FDA approvals for Clearside Biomedical (CLSD). This TTM year-over-year revenue chart measures the growth rates of trailing twelve-month income relative to the previous year. This metric smooths out seasonal fluctuations, revealing the true vector of business expansion. The positive trend confirms the scaling of the injection ecosystem; however, peak values may signal an inflated market capitalization for the asset.

Who Clearside Biomedical competes with

ALC - Revenue Growth YoY (Last 12 Months)|BLCO: Revenue Growth YoY (Last 12 Months)|GKOS - Sales Growth YoY (TTM)|Apellis (APLS) - Sales Growth YoY (Last Twelve Months)|BLTE - Annual Revenue Growth (Last Twelve Months)|OCUL (Ocular Therapeutix Inc) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Harrow, Inc. HROW|Sales Growth YoY (TTM) VRDN|Revenue Change YoY (Last 12 Months) LENZ|oculis.com - Revenue Growth YoY (Last 12 Months)|EYPT: Sales Growth YoY (Last 12 Months)|Kodiak Corp - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) ALDX (Aldeyra Therapeutics Inc.)|KALA (Kala Pharmaceuticals) - Revenue Growth YoY (Last 12 Months)|IRD: Revenue Change YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) okyopharma.com|adverum.com (ADVM) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) OTLK|NBY (NovaBay Pharmaceuticals Inc.) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) KPRX (Kiora Pharmaceuticals Inc.)|Alimera Sciences (ALIM) - Trailing Twelve Months Revenue Growth|EYEN: Revenue Growth YoY (Last 12 Months)|GHSI: Sales Growth YoY (Last Twelve Months)|Ocuphire Corporation (OCUP) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Opthea Corp (OPT)